Influvac Tetra 2025 - Quadrivalent Influenza Vaccine (0.5 mL Syringe)

Influvac Tetra 2025 - Quadrivalent Influenza Vaccine (0.5 mL Syringe)

Benefits:

Protects against 4 influenza strains: 2 A and 2 B (Quadrivalent protection)

Updated annually to match circulating flu virus strains

Suitable for adults, children (6 months+), and pregnant or breastfeeding women

Can reduce flu-related complications and hospitalisations

Convenient single-dose 0.5 mL pre-filled syringe

ARTG registered: AUST R 292237

Age Group:

6 months and older

How to Use:

Administration: Intramuscular or subcutaneous injection

Dosage:

Adults & children over 6 months: One 0.5 mL dose

Children <9 years receiving for the first time: Two doses 4 weeks apart

Should only be administered by a healthcare professional

Annual vaccination is recommended before flu season

Product Info:

Form: Injection, inactivated virus (surface antigen)

Presentation: Clear, colourless pre-filled syringe

Needle: 16 mm needle included

Packaging: Available in single (1 syringe) or multi-pack (10 syringes)

Storage Instructions:

Store in refrigerator: 2°C to 8°C

Do not freeze

Protect from light

Keep out of reach of children

Common Side Effects:

Pain, redness, or swelling at the injection site

Headache, fatigue, muscle or joint aches

Fever, shivering, sweating

In children: vomiting, diarrhoea, drowsiness, irritability

Serious Side Effects (Rare):

Allergic reactions (e.g. facial swelling, difficulty breathing)

Severe fatigue or weakness

If serious side effects occur, seek emergency medical care immediately.

Ingredients (Active):

Each 0.5 mL dose contains 15 µg of HA of each virus strain:

A/Victoria/4897/2022 (H1N1)pdm09-like

A/Croatia/10136RV/2023 (H3N2)-like

B/Austria/1359417/2021 (B/Victoria lineage)

B/Phuket/3073/2013 (B/Yamagata lineage)